CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall
Open Access
- 1 August 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (3) , 1092-1093
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- E1A3 as a unique, naturally occurring BCR–ABL transcript in an indolent case of chronic myeloid leukaemiaBritish Journal of Haematology, 2001
- Are aberrant BCR-ABL transcripts more common than previously thought?British Journal of Haematology, 2000
- Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patientsBlood, 2000
- Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for LeukemogenesisJournal of Experimental Medicine, 1999
- The SH3 Domain Contributes to BCR/ABL-Dependent Leukemogenesis In Vivo: Role in Adhesion, Invasion, and HomingBlood, 1998
- The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]Blood, 1996